A health impact assessment of increased aspirin use in Wales.
To estimate the likely magnitude of health impact if all individuals at increased risk of cardiovascular events in Wales (total population 2.9 million) took low-dose aspirin. Data from a variety of different sources were collected and systematically combined using simple methods and conservative assumptions. Aspirin may reduce cardiovascular mortality by 2-25% and avoid 330-3250 deaths per annum after allowing for a small number of fatal undesirable effects. Wales might lead the way in developing an aspirin programme.